- 如果營收成長率小於推銷費用成長率, 可能代表產品需要很多的促銷才能賣掉, 或是產品有問題需要花額外的推銷成本來善後
- 發展品牌的公司不樂見推銷費用率的下滑, 對此類型公司推銷費用率等同於走技術類型公司的研發費用率
| 營收淨額 QoQ YoY | 推銷費用 QoQ YoY | 管理費用 QoQ YoY | 研發費 QoQ YoY | 推銷費用率(%) QoQ YoY | 管理費用率(%) QoQ YoY | 研發費用率(%) QoQ YoY | 員工人數 QoQ YoY | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24Q3 (20) | 54.86 | -0.8 | 44.79 | 0 | 0 | 0 | 0.38 | -7.32 | -11.63 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0.69 | -6.57 | -38.96 | 0.00 | 0 | 0 | 166 | 0.0 | 1.22 |
| 24Q2 (19) | 55.3 | 17.81 | 17.09 | 0 | 0 | 0 | 0.41 | 13.89 | 5.13 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0.74 | -3.33 | -10.21 | 0.00 | 0 | 0 | 166 | 0.0 | 1.22 |
| 24Q1 (18) | 46.94 | -4.11 | 30.82 | 0 | 0 | 0 | 0.36 | -10.0 | 2.86 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0.77 | -6.15 | -21.38 | 0.00 | 0 | 0 | 166 | 0.0 | 1.22 |
| 23Q4 (17) | 48.95 | 29.19 | -6.78 | 0 | 0 | 0 | 0.4 | -6.98 | -36.51 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0.82 | -27.99 | -31.89 | 0.00 | 0 | 0 | 166 | 1.22 | 1.22 |
| 23Q3 (16) | 37.89 | -19.78 | -40.13 | 0 | 0 | 0 | 0.43 | 10.26 | -12.24 | 0 | 0 | 0 | 0.00 | 0 | 0 | 1.13 | 37.43 | 46.58 | 0.00 | 0 | 0 | 164 | 0.0 | 0.61 |
| 23Q2 (15) | 47.23 | 31.63 | -37.69 | 0 | 0 | 0 | 0.39 | 11.43 | -23.53 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0.83 | -15.35 | 22.73 | 0.00 | 0 | 0 | 164 | 0.0 | 0.61 |
| 23Q1 (14) | 35.88 | -31.67 | -37.64 | 0 | 0 | 0 | 0.35 | -44.44 | -14.63 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0.98 | -18.7 | 36.9 | 0.00 | 0 | 0 | 164 | 0.0 | 0.61 |
| 22Q4 (13) | 52.51 | -17.03 | -15.13 | 0 | 0 | 0 | 0.63 | 28.57 | -1.56 | 0 | 0 | 0 | 0.00 | 0 | 0 | 1.20 | 54.97 | 15.98 | 0.00 | 0 | 0 | 164 | 0.61 | 0.61 |
| 22Q3 (12) | 63.29 | -16.5 | 24.17 | 0 | 0 | 0 | 0.49 | -3.92 | 19.51 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0.77 | 15.07 | -3.75 | 0.00 | 0 | 0 | 163 | 0.0 | 0.0 |
| 22Q2 (11) | 75.8 | 31.73 | 74.33 | 0 | 0 | 0 | 0.51 | 24.39 | 30.77 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0.67 | -5.58 | -24.99 | 0.00 | 0 | 0 | 163 | 0.0 | 0.0 |
| 22Q1 (10) | 57.54 | -7.0 | 62.63 | 0 | 0 | 0 | 0.41 | -35.94 | 10.81 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0.71 | -31.12 | -31.87 | 0.00 | 0 | 0 | 163 | 0.0 | 0.0 |
| 21Q4 (9) | 61.87 | 21.39 | 88.05 | 0 | 0 | 0 | 0.64 | 56.1 | 56.1 | 0 | 0 | 0 | 0.00 | 0 | 0 | 1.03 | 28.6 | -16.99 | 0.00 | 0 | 0 | 163 | 0.0 | 0.0 |
| 21Q3 (8) | 50.97 | 17.23 | 62.69 | 0 | 0 | 0 | 0.41 | 5.13 | 5.13 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0.80 | -10.32 | -35.38 | 0.00 | 0 | 0 | 163 | 0.0 | 1.88 |
| 21Q2 (7) | 43.48 | 22.89 | 59.56 | 0 | 0 | 0 | 0.39 | 5.41 | 11.43 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0.90 | -14.23 | -30.16 | 0.00 | 0 | 0 | 163 | 0.0 | 1.88 |
| 21Q1 (6) | 35.38 | 7.54 | 26.76 | 0 | 0 | 0 | 0.37 | -9.76 | -5.13 | 0 | 0 | 0 | 0.00 | 0 | 0 | 1.05 | -16.08 | -25.16 | 0.00 | 0 | 0 | 163 | 0.0 | 6.54 |
| 20Q4 (5) | 32.9 | 5.01 | -3.6 | 0 | 0 | 0 | 0.41 | 5.13 | 2.5 | 0 | 0 | 0 | 0.00 | 0 | 0 | 1.25 | 0.11 | 6.33 | 0.00 | 0 | 0 | 163 | 1.88 | 6.54 |
| 20Q3 (4) | 31.33 | 14.97 | 0.0 | 0 | 0 | 0.0 | 0.39 | 11.43 | 0.0 | 0 | 0 | 0.0 | 0.00 | 0 | 0.0 | 1.24 | -3.08 | 0.0 | 0.00 | 0 | 0.0 | 160 | 0.0 | 0.0 |
| 20Q2 (3) | 27.25 | -2.36 | 0.0 | 0 | 0 | 0.0 | 0.35 | -10.26 | 0.0 | 0 | 0 | 0.0 | 0.00 | 0 | 0.0 | 1.28 | -8.08 | 0.0 | 0.00 | 0 | 0.0 | 160 | 4.58 | 0.0 |
| 20Q1 (2) | 27.91 | -18.22 | 0.0 | 0 | 0 | 0.0 | 0.39 | -2.5 | 0.0 | 0 | 0 | 0.0 | 0.00 | 0 | 0.0 | 1.40 | 19.23 | 0.0 | 0.00 | 0 | 0.0 | 153 | 0.0 | 0.0 |
| 19Q4 (1) | 34.13 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0.4 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0.00 | 0.0 | 0.0 | 1.17 | 0.0 | 0.0 | 0.00 | 0.0 | 0.0 | 153 | 0.0 | 0.0 |
| 營收淨額 YoY | 推銷費用 YoY | 管理費用 YoY | 研發費 YoY | 推銷費用率(%) YoY | 管理費用率(%) YoY | 研發費用率(%) YoY | 員工人數 YoY | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | 169.95 | -31.78 | 0 | 0 | 1.57 | -22.66 | 0 | 0 | 0.00 | 0 | 0.92 | 13.37 | 0.00 | 0 | 164 | 0.0 |
| 2022 (9) | 249.13 | 29.97 | 0 | 0 | 2.03 | 11.54 | 0 | 0 | 0.00 | 0 | 0.81 | -14.18 | 0.00 | 0 | 164 | 0.61 |
| 2021 (8) | 191.69 | 60.56 | 0 | 0 | 1.82 | 18.95 | 0 | 0 | 0.00 | 0 | 0.95 | -25.91 | 0.00 | 0 | 163 | 0.0 |
| 2020 (7) | 119.39 | -13.69 | 0 | 0 | 1.53 | 2.0 | 0 | 0 | 0.00 | 0 | 1.28 | 18.18 | 0.00 | 0 | 163 | 1.88 |
| 2019 (6) | 138.33 | 5.85 | 0 | 0 | 1.5 | 6.38 | 0 | 0 | 0.00 | 0 | 1.08 | 0.5 | 0.00 | 0 | 160 | 4.58 |
| 2018 (5) | 130.68 | 18.38 | 0 | 0 | 1.41 | -11.88 | 0 | 0 | 0.00 | 0 | 1.08 | -25.56 | 0.00 | 0 | 153 | 6.99 |
| 2017 (4) | 110.39 | 3.37 | 0 | 0 | 1.6 | 0 | 0 | 0 | 0.00 | 0 | 1.45 | 0 | 0.00 | 0 | 143 | 3.62 |
| 2016 (3) | 106.79 | -3.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 138 | -93.8 |
| 2015 (2) | 110.12 | 21.59 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 2226 | 13.98 |
| 2014 (1) | 90.57 | 8.75 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 1953 | 4.89 |
